Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

British industry leaders fear tariffs imposed by President Trump could disrupt the supply and even the price of drugs ...

British industry leaders fear tariffs imposed by President Trump could disrupt the supply and even the price of drugs ...

The obesity drug market has experienced a seismic shift in recent years, with Novo Nordisk's (NOV: N) Wegovy (semaglutide) ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...